Barry S. Duke

2016

In 2016, Barry S. Duke earned a total compensation of $833.8K as Executive Vice President and Chief Commercial Officer at Collegium Pharmaceutical, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$102,099
Option Awards$317,040
Salary$334,586
Stock Awards$78,739
Other$1,303
Total$833,767

Duke received $334.6K in salary, accounting for 40% of the total pay in 2016.

Duke also received $102.1K in non-equity incentive plan, $317K in option awards, $78.7K in stock awards and $1.3K in other compensation.

Rankings

In 2016, Barry S. Duke's compensation ranked 9,105th out of 14,075 executives tracked by ExecPay. In other words, Duke earned more than 35.3% of executives.

ClassificationRankingPercentile
All
9,105
out of 14,075
35th
Division
Manufacturing
3,521
out of 5,489
36th
Major group
Chemicals And Allied Products
1,213
out of 1,895
36th
Industry group
Drugs
960
out of 1,538
38th
Industry
Pharmaceutical Preparations
763
out of 1,176
35th
Source: SEC filing on April 13, 2017.

Duke's colleagues

We found five more compensation records of executives who worked with Barry S. Duke at Collegium Pharmaceutical in 2016.

2016

Michael Ph

Collegium Pharmaceutical

Chief Executive Officer

2016

Michael Heffernan

Collegium Pharmaceutical

Chief Executive Officer

2016

Michael Ph

Collegium Pharmaceutical

Founder

2016

Paul Brannelly

Collegium Pharmaceutical

Chief Financial Officer

2016

Alison Fleming

Collegium Pharmaceutical

Chief Technology Officer

You may also like